Showing results (31-40 of 51) with videos related to
Sort By:
Pageof 6
Cell Reports|April 6, 2025
PLK1 blockade enhances the anti-tumor effect of MAPK inhibition in pancreatic ductal adenocarcinomaBen Zhao, Rui Fang, Hendrik Schürmann, et al.Cells|July 6, 2023
Fibroblast Activation Protein-Targeting Minibody-IRDye700DX for Ablation of the Cancer-Associated Fibroblast with Photodynamic TherapyEsther M M Smeets, Daphne N Dorst, Gerben M Franssen, et al.European Journal of Nuclear Medicine and Molecular Imaging|September 8, 2022
Functional biomarkers derived from computed tomography and magnetic resonance imaging differentiate PDAC subgroups and reveal gemcitabine-induced hypo-vascularizationIrina Heid, Marija Trajkovic-Arsic, Fabian Lohöfer, et al.Molecular Oncology|October 31, 2024
Minimally invasive determination of pancreatic ductal adenocarcinoma (PDAC) subtype by means of circulating cell-free RNAMartin Metzenmacher, Gregor Zaun, Marija Trajkovic-Arsic, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 20, 2014
Multimodal molecular imaging of integrin αvβ3 for in vivo detection of pancreatic cancerMarija Trajkovic-Arsic, Pouyan Mohajerani, Athanasios Sarantopoulos, et al.International Journal of Cancer|June 30, 2020
Characterization of a dual BET/HDAC inhibitor for treatment of pancreatic ductal adenocarcinomaXin Zhang, Tim Zegar, Tim Weiser, et al.Clinical Epigenetics|January 16, 2024
Pancreatic cancer acquires resistance to MAPK pathway inhibition by clonal expansion and adaptive DNA hypermethylationLaura K Godfrey, Jan Forster, Sven-Thorsten Liffers, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 6, 2023
LAMC2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer GrowthOihane Erice, Shruthi Narayanan, Iker Feliu, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 6, 2023
Superior Tumor Detection for 68Ga-FAPI-46 Versus 18F-FDG PET/CT and Conventional CT in Patients with CholangiocarcinomaKim M Pabst, Marija Trajkovic-Arsic, Phyllis F Y Cheung, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 3, 2024
Fibroblast Activation Protein-Directed Imaging Outperforms 18F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational TrialLukas Kessler, Felix Schwaning, Martin Metzenmacher, et al.Pageof 6